Medasense Biometrics

Noninvasive Pain-monitoring Solutions

Startup

Medasense Biometrics is a Ramat Gan-based startup in the Health Tech & Life Sciences sector, established in 2008. Noninvasive Pain-monitoring Solutions. The company has raised a total of $33.5M across 5 funding rounds, currently at the C stage. Medasense Biometrics was founded by Galit Zuckerman. Key investors include BIRD Foundation, Sabadell Asabys VC, OTV, among 9 total investors. The company has 11-50 employees. Core technologies: Artificial Intelligence, Sensing, Biometrics.

With $33.5M in total funding, Medasense Biometrics is a C-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released. The company holds 1 patent.

$33.5M
Raised
5
Rounds
9
Investors
3
Team
2008
Founded
1
Patents
Sector & Technology
Health Tech & Life SciencesDigital HealthcarePatient Remote MonitoringMedical DevicesMedical MonitorsArtificial IntelligenceSensingBiometrics
At a Glance
Investors

9 investors total

Founders
In the News

17 articles covered by sources including www.calcalistech.com, www.prnewswire.co.uk, www.prnewswire.com, www.israel21c.org, en.globes.co.il.

www.calcalistech.com · Feb 28, 2023
FDA authorizes marketing of Medasense's NOL technology to measure pain in anesthetized patients | CTech
Read article ↗
Frequently Asked Questions
What does Medasense Biometrics do?

Medasense offers a technology that enables clinicians to optimize and personalize pain control and avoid overmedication. Medasense's flagship product, the PMD-200 with its NOL index, is a platform that objectively monitors and quantifies the patient's pain response by means of artificial intelligence and a proprietary noninvasive sensor platform. The PMD-200 is used to optimize pain management in operating rooms and critical care settings, where patients are unable to communicate. The PMD-200 is distributed in Europe exclusively by Medtronic. It is also cleared for marketing in Canada, Latin America, Israel, and Australia. It enables connectivity with Philips patient monitors. Clinical studies have demonstrated its impact on patient safety and outcomes, including opioid sparing.

How much funding has Medasense Biometrics raised?

Medasense Biometrics has raised $33.5M in total funding across 5 rounds. The company is currently at the C stage. Key investors include BIRD Foundation, Sabadell Asabys VC, OTV.

Who founded Medasense Biometrics?

Medasense Biometrics was founded in 2008 by Galit Zuckerman (Co-founder & CEO).

What sector is Medasense Biometrics in?

Medasense Biometrics operates in Health Tech & Life Sciences, Digital Healthcare, Patient Remote Monitoring, Medical Devices, Medical Monitors, with core technologies in Artificial Intelligence, Sensing, Biometrics. Target customers: Healthcare & Life Sciences, Healthcare, Providers.

Where is Medasense Biometrics located?

Medasense Biometrics is based in Hahilazon Street 4, Ramat Gan, Israel, Center District. The company also has offices abroad.

View Full Profile Classic View Website ↗